维普中文期刊产品整合服务
58篇 您的检索式:作者名="Rauck"
    题名 作者 年代 出处 被引量
1术后镇痛方法显示文摘肌注镇痛药已不再是唯一的术后镇痛方法,不少新方法均能提供良好镇痛,降低并发症发病率和死亡率,改善肺功能,病人可早期活动,缩短住院时间,镇痛药用量亦减少。近十年最常用的方法是留置导管,导管可放置于硬膜外腔、一侧臂丛或胸膜腔内,保留1~7天。术后早期也可在交感链和/或神经节处注射局麻药来止痛。随着技术的进展,生产的导管细而坚韧。Rauck RL 汪正平 1991国外医学(麻醉学与复苏分册)1991,12,4:12
2NGX-4010,a eapsa- icin 8 dermal patch, administered alone or in combina- tion with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia 显示文摘Irving G Baekonja M Rauck R 2012Clin J Pain2012,28,2:1
3Cystatin C in cerebrospinal fluid is mot a diagnostic test for pain in hu-mans显示文摘Eisenach JC Thomas JA Rauck RL 2004Pain2004,107,3:1
4Lacosamide in painful diabetic peripheral neuropathy:a phase 2 double-blind placebo- contralled study clin显示文摘Rauck RL Shaibani A Boiton V 2007Pain2007,23,2:1
5Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long- term opioid treatment for chronic pain显示文摘Reynolds L Rauck R Webster 2004Pain2004,110,12:1
6Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans显示文摘Eisenach JC Thomas JA Rauck RL 2004Pain2004,107,3:1
7Intrathecal,but not intravenous adenosine reduces allodynia in patients with neuropathic pain显示文摘Eisenach J.C Rauck R.L Curry R 0,,:1
8A randomized,controlled trial of gabapentin enaearbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy显示文摘Rauck R Makumi CW Schwartz S 2013Pain Pratt2013,13,6:1
9Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans显示文摘Eisenach JC Thomas JA Rauck RL 2004Pain2004,107,3:1
10Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in human 显示文摘Eisenach JC Thomas JA Rauck RL 2004Pain2004,107,3:1
11A randomized, doub- le-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain 显示文摘Rauck RL Wallace MS Leong MS 2006J Pain Symptom Manage2006,31,5:1
12Intrathecal gabapentin to treat chronic intractable noncancer pain 显示文摘Rauck R Coffey RJ Schultz DM 2013Anesthesiology2013,119,3:1
13Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain显示文摘Rauck RL Tark M Reyes E 2009Curr Med Res Opin2009,25,12:1
14Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer:a randomized,double-blind,placebo-controlled study显示文摘Rauck R North J Gever LN 2009Ann Oncol2009,,:1
15Lacosamide in painful dia- betic peripheral neuropathy: a phase 2 double-blind placebo-con- trolled study显示文摘Rauck RL Shaibani A Biton V 2007Clin J Pain2007,23,:1
16Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an openlabel, long-term trial 显示文摘Wallace MS Rauck R Charapata SG 2008Anesth Analg2008,106,2:1
17抗血小板和抗凝患者行脊柱介入和疼痛介入治疗指南(一)显示文摘疼痛介入治疗涵盖了较局部神经阻滞更为广泛的内容,两者具有不同的目的和治疗靶点。参加ASRA第11届疼痛医学年会的脊柱、疼痛科及介入科医师参与调查时表示:由于介入技术的发展,ASRA现有的、关于局部神经阻滞中有关抗血小板和抗凝患者的相关指南已经不能满足临床需要。受访者一致认为,由于介入治疗与局部神经阻滞在适应证和操作上存在差异,需针对疼痛介入治疗制订单独的临床指南。对此,ASRA成立了指南委员会,通过查阅脊柱和疼痛治疗相关并发症的文献,委员会根据潜在的出血风险将脊柱和疼痛介入治疗分为低、中、高三个级别。该指南主要适用于中、低风险治疗级别,而高风险操作需要进一步权衡患者安全和最佳预后。指南制订委员会采用极为全面的数据库检索方法收集最新的相关文献,尽可能为读者提供循证推荐。然而,由于许多原始文献缺乏针对疼痛介入治疗来设计的大型研究证据的支持,指南制订委员会难以提供这些证据的强度和级别,尽管有些指南或共识的制订不全基于随机对照研究或大样本患者数据库,但希望这些指南能提供良好的临床建议和类似指南的证据基础。Samer Narouze Honorio T.Benzon David A.Provenzano Asokumar Buvanendran José De Andres Timothy R.Deer Richard Rauck Marc A.Huntoon 易晓彬 姚鹏 金毅 卫炯琳 方铮 解轶声 吴安石 鄢建勤 李水清 孙永海 肖军 樊碧发 2016中国疼痛医学杂志2016,22,6:1
18Lacosamide in painful diabetic peripheral neuropathy:a phase 2 double-blind placebocontralled study clin显示文摘Rauck ELyShaibani A Boiton V 2007Pain2007,23,2:1
19Comparison of the effi- cacy of epidural morphine given by intermittent injection or continuous infusion for the management of postoperative pain 显示文摘Rauck RL Raj PP Knarr DC 1994Reg Anesth1994,19,5:1
20Cystatin C in cere- brospinal fluid is not a diagnostic test for pain in humans显示文摘Eisenach JC Thomas JA Rauck RL 2004Pain2004,107,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费